Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct 6;13(10):e077676.
doi: 10.1136/bmjopen-2023-077676.

iVY: protocol for a randomised clinical trial to test the effect of a technology-based intervention to improve virological suppression among young adults with HIV in the USA

Parya Saberi #  1 , Marie C D Stoner #  2 , Caravella L McCuistian  3 , Celeste Balaban  1 , Kristin Ming  1 , Danielle Wagner  4 , Bibhas Chakraborty  5   6   7 , Louis Smith  1 , Adam Sukhija-Cohen  8 , Torsten B Neilands  1 , Valerie A Gruber  3 , Mallory O Johnson  1
Affiliations

iVY: protocol for a randomised clinical trial to test the effect of a technology-based intervention to improve virological suppression among young adults with HIV in the USA

Parya Saberi et al. BMJ Open. .

Abstract

Introduction: Young adults with HIV (YWH) experience worse clinical outcomes than adults and have high rates of substance use (SU) and mental illness that impact their engagement in care and adherence to antiretroviral therapy (ART). The intervention for Virologic Suppression in Youth (iVY) aims to address treatment engagement/adherence, mental health (MH) and SU in a tailored manner using a differentiated care approach that is youth friendly. Findings will provide information about the impact of iVY on HIV virological suppression, MH and SU among YWH who are disproportionately impacted by HIV and at elevated risk for poor health outcomes.

Methods and analysis: The iVY study will test the effect of a technology-based intervention with differing levels of resource requirements (ie, financial and personnel time) in a randomised clinical trial with an adaptive treatment strategy among 200 YWH (18-29 years old). The primary outcome is HIV virological suppression measured via dried blood spot. This piloted and protocolised intervention combines: (1) brief weekly sessions with a counsellor via a video-chat platform (video-counselling) to discuss MH, SU, HIV care engagement/adherence and other barriers to care; and (2) a mobile health app to address barriers such as ART forgetfulness, and social isolation. iVY has the potential to address important, distinct and changing barriers to HIV care engagement (eg, MH, SU) to increase virological suppression among YWH at elevated risk for poor health outcomes.

Ethics and dissemination: This study and its protocols have been approved by the University of California, San Francisco Institutional Review Board. Study staff will work with a Youth Advisory Panel to disseminate results to YWH, participants and the academic community.

Trial registration number: NCT05877729.

Keywords: HIV & AIDS; MENTAL HEALTH; Substance misuse; Telemedicine.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Overview of study design. SOC, standard of care.
Figure 2
Figure 2
Mobile app screenshots.
See this image and copyright information in PMC

References

    1. Centers for disease control and prevention . Selected national HIV prevention and care outcomes 2017, Available: https://www.cdc.gov/hiv/pdf/library/slidesets/cdc-hiv-prevention-and-car...
    1. Harris NS, Johnson AS, Huang Y-L, et al. Vital signs: status of human immunodeficiency virus testing, viral suppression, and HIV preexposure prophylaxis - United States, 2013-2018. MMWR Morb Mortal Wkly Rep 2019;68:1117–23. 10.15585/mmwr.mm6848e1 - DOI - PMC - PubMed
    1. Kapogiannis BG, Koenig LJ, Xu J, et al. The HIV continuum of care for adolescents and young adults attending 13 urban US HIV care centers of the NICHD-ATN-CDC-HRSA SMILE collaborative. J Acquir Immune Defic Syndr 2020;84:92–100. 10.1097/QAI.0000000000002308 - DOI - PMC - PubMed
    1. Doshi RK, Milberg J, Jumento T, et al. For many served by the ryan white HIV/AIDS program, disparities in viral suppression decreased, 2010-14. Health Aff (Millwood) 2017;36:116–23. 10.1377/hlthaff.2016.0655 - DOI - PubMed
    1. Doshi RP, Aseltine RH, Sabina AB, et al. Racial and ethnic disparities in preventable hospitalizations for chronic disease: prevalence and risk factors. J Racial Ethn Health Disparities 2017;4:1100–6. 10.1007/s40615-016-0315-z - DOI - PubMed

Publication types

Associated data